Allen Hauser W, Annegers JF. Descriptive epidemiology of epilepsy: Contributions of population-based studies from rochester, minnesota. Mayo Clin Proc. 1996;71(6):576–86.

Olafsson E, Ludvigsson P, Hesdorffer D, Kjartansson O, Hauser WA, Gudmundsson G. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol [Internet]. 2005;4(10):627–34. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1474442205701721

Forsgren L, Beghi E, Õun A, Sillanpää M. The epidemiology of epilepsy in Europe - A systematic review. Eur J Neurol. 2005;12:245–53.

Article  CAS  PubMed  Google Scholar 

Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: A practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–82.

Article  PubMed  Google Scholar 

Kim LG, Johnson TL, Marson AG, Chadwick DW. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol. 2006;5(4):317–22.

Article  PubMed  Google Scholar 

Singh G, Rees JH, Sander JW. Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment. J Neurol Neurosurg Psychiatry. 2006;78(4):342–9.

Article  Google Scholar 

Herman ST. Epilepsy after brain insult. Neurology. 2002;59(9_suppl_5).

Lote K, Stenwig AE, Skullerud K, Hirschberg H. Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer. 1998;34(1):98–102.

Article  CAS  PubMed  Google Scholar 

van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6(5):421–30.

Article  PubMed  Google Scholar 

Rahman Z, Wong CH, Dexter M, Olsson G, Wong M, Gebsky V, et al. Epilepsy in patients with primary brain tumors: the impact on mood, cognition, and HRQOL. Epilepsy Behav. 2015;48:88–95.

Article  CAS  PubMed  Google Scholar 

Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: A European study. Epilepsia. 1997;38(3):353–62.

Article  CAS  PubMed  Google Scholar 

Waagemans ML, van Nieuwenhuizen D, Dijkstra M, Wumkes M, Dirven CMF, Leenstra S, et al. Long-term impact of cognitive deficits and epilepsy on quality of life in patients with Low-Grade meningiomas. Neurosurgery. 2011;69(1):72–9.

Article  PubMed  Google Scholar 

Maschio M, Sperati F, Dinapoli L, Vidiri A, Fabi A, Pace A, et al. Weight of epilepsy in brain tumor patients. J Neurooncol. 2014;118(2):385–93.

Article  PubMed  Google Scholar 

Vingerhoets G. Cognitive effects of seizures. Seizure. 2006;15(4):221–6.

Article  PubMed  Google Scholar 

Novak A, Vizjak K, Rakusa M. Cognitive impairment in people with epilepsy. J Clin Med. 2022;11(1):267.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3(3):159–68.

Article  PubMed  Google Scholar 

Avila EK, Chamberlain M, Schiff D, Reijneveld JC, Armstrong TS, Ruda R, et al. Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. Volume 19. Neuro-Oncology: Oxford University Press; 2017. pp. 12–21.

Google Scholar 

Aroosa M, Malik JA, Ahmed S, Bender O, Ahemad N, Anwar S. The evidence for repurposing anti-epileptic drugs to target cancer. Molecular Biology Reports. Volume 50. Springer Science and Business Media B.V.; 2023. pp. 7667–80.

Grimi A, Bono BC, Lazzarin SM, Marcheselli S, Pessina F, Riva M. Gliomagenesis, epileptogenesis, and remodeling of neural circuits: relevance for novel treatment strategies in Low- and High-Grade gliomas. Int J Mol Sci 2024;25.Multidisciplinary Digital Publishing Institute (MDPI).

Julie DAR, Ahmed Z, Karceski SC, Pannullo SC, Schwartz TH, Parashar B et al. An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy. Seizure. 2019;70:30–7. W.B. Saunders Ltd

Grewal J, Grewal HK, Forman AD. Seizures and Epilepsy in Cancer: Etiologies, Evaluation, and Management. 2008.

Avila EK, Tobochnik S, Inati SK, Koekkoek JAF, McKhann GM, Riviello JJ, et al. Brain tumor-related epilepsy management: A society for Neuro-oncology (SNO) consensus review on current management. Volume 26. Neuro-Oncology: Oxford University Press; 2024. pp. 7–24.

Google Scholar 

Avila EK, Graber J. Seizures and epilepsy in Cancer patients. Curr Neurol Neurosci Rep. 2010;10(1):60–7.

Article  PubMed  Google Scholar 

Li L, Fang S, Li G, Zhang K, Huang R, Wang Y, et al. Glioma-related epilepsy in patients with diffuse high-grade glioma after the 2016 WHO update: seizure characteristics, risk factors, and clinical outcomes. J Neurosurg. 2022;136(1):67–75.

Article  CAS  PubMed  Google Scholar 

Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia. 2010;51(7):1236–41.

Article  PubMed  Google Scholar 

Jo J, Nevel K, Sutyla R, Smolkin M, Lopes MB, Schiff D. Predictors of early, recurrent, and intractable seizures in low-grade glioma. Neurooncol Pract. 2021;8(1):40–7.

PubMed  Google Scholar 

Mehrotra A, Singh S, Kanjilal S, Kumar A, Pal L, Mathur V, et al. Long-Term Epilepsy-Associated tumors (LEATs): A Single-Center, retrospective series and review of literature on factors affecting the seizure outcome. World Neurosurg. 2020;144:e149–55.

Article  PubMed  Google Scholar 

Tobochnik S, Dorotan MKC, Ghosh HS, Lapinskas E, Vogelzang J, Reardon DA, et al. Glioma genetic profiles associated with electrophysiologic hyperexcitability. Neuro Oncol. 2024;26(2):323–34.

Article  CAS  PubMed  Google Scholar 

Prabowo AS, Iyer AM, Veersema TJ, Anink JJ, Schouten-van Meeteren AYN, Spliet WGM, et al. BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors. Brain Pathol. 2014;24(1):52–66.

Article  CAS  PubMed  Google Scholar 

Gupte TP, Li C, Jin L, Yalcin K, Youngblood MW, Miyagishima DF, et al. Clinical and genomic factors associated with seizures in meningiomas. J Neurosurg. 2021;135(3):835–44.

Article  PubMed  Google Scholar 

Englot DJ, Magill ST, Han SJ, Chang EF, Berger MS, McDermott MW. Seizures in supratentorial meningioma: a systematic review and meta-analysis. J Neurosurg. 2016;124(6):1552–61.

Article  PubMed  Google Scholar 

Koh HY, Kim SH, Jang J, Kim H, Han S, Lim JS, et al. BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors. Nat Med. 2018;24(11):1662–8.

Article  CAS  PubMed  Google Scholar 

Escudier B, Thompson JA. Mechanism of action of everolimus in renal cell carcinoma. Med Oncol. 2009;26(S1):32–9.

Article  Google Scholar 

Franz DN, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, et al. Everolimus for treatment-refractory seizures in TSC: extension of a randomized controlled trial. Neurol Clin Pract. 2018;8(5):412–20.

Article  PubMed  PubMed Central  Google Scholar 

Innes SC, Joe DK, Cikurel K, Lavrador JP, Vergani F, Bhangoo R, et al. Consequences of acute presentations of functional neurological disorders in Neuro-oncology patients. Case Series and Systematic Review; 2024.

Sumangala S, Liang D, Samarasekera S. Nonepileptic attacks in patients with brain tumor-related epilepsy. Epilepsy Behav. 2022;129.

Garcia CR, Khan GQ, Morrow AM, Yadav P, Lightner DD, Gilliam FG, et al. Brain tumors associated with psychogenic non-epileptic seizures: case series. Clin Neurol Neurosurg. 2018;164:53–6.

Article  PubMed  Google Scholar 

Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B. The course of seizure disorders in patients with malignant gliomas. arch neurol [Internet]. 1995;52(7):717–24. Available from: http://archneur.jamanetwork.com/article.aspx?articleid=593554

Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors report of the Quality Standards Subcommittee of the American Academy of Neurology [Internet]. 2000. Available from: https://www.neurology.org

Horiuchi S, Kanaya K, Horiuchi T. The occurrence and relationship of postoperative seizure and de Novo epilepsy after craniotomy surgery: A retrospective Single-Center cohort study. Front Surg. 2022;9.

Greenhalgh J, Weston J, Dundar Y, Nevitt SJ, Marson AG. Antiepileptic drugs as prophylaxis for postcraniotomy seizures. Cochrane Database Syst Reviews. 2020.

Mirian C, Møller Pedersen M, Sabers A, Mathiesen T. Antiepileptic drugs as prophylaxis for de Novo brain tumour-related epilepsy after craniotomy: a systematic review and meta-analysis of harm and benefits. J Neurol Neurosurg Psychiatry. 2019;90(5):599–607.

Article  PubMed  Google Scholar 

Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS. Seizure prophylaxis in patients with brain tumors: A Meta-analysis. Mayo Clin Proc. 2004;79(12):1489–94.

Islim AI, McKeever S, Kusu-Orkar TE, Jenkinson MD. The role of prophylactic antiepileptic drugs for seizure prophylaxis in meningioma surgery: A systematic review. J Clin Neurosci. 2017;43:47–53.

Article  CAS  PubMed  Google Scholar 

Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: Meta-Analysis of controlled trials. Epilepsia. 2001;42(4):515–24.

Article  CAS  PubMed  Google Scholar 

Chen CC, Rennert RC, Olson JJ. Congress of neurological surgeons systematic review and Evidence-Based guidelines on the role of prophylactic anticonvulsants in the treatment of adults with metastatic brain tumors. Neurosurgery. 2019;84(3):E195–7.

Article